短期重复血管内给予碘对比剂或钆对比剂的肾脏安全性
回顾性纳入300例疑似急性卒中且基线eGFR≥30 mL/min/1.73 m²的患者,分析短期重复血管内给予碘对比剂是否增加对比剂后急性肾损伤风险。单次剂量组、0-4小时组和4-48小时组的AKI发生率分别为7.2%、13.8%和8.6%,校正合并症和肾毒性药物后,重复给予碘对比剂与AKI无显著关联(所有p值>0.05)。
要点
- 疑似急性卒中且基线eGFR≥30 mL/min/1.73 m²者,短期重复碘对比剂未显著增加AKI风险。
- 0-4小时重复组AKI发生率13.8%,单次组7.2%,但多因素校正后差异无统计学意义。
核心结论
- 在疑似急性卒中且基线eGFR≥30 mL/min/1.73 m²的患者中,短期重复血管内给予碘对比剂未增加AKI风险。
研究设计与样本
- 回顾性研究,纳入300例至少接受一次碘对比剂增强脑灌注CT且基线与随访血肌酐可用的患者,按对比剂重复间隔分为单次剂量组(207例)、0-4小时组(58例)和4-48小时组(35例)。
诊断标准与关键数值
- AKI发生率:单次剂量组7.2%,0-4小时组13.8%,4-48小时组8.6%;校正合并症和肾毒性药物后,0-4小时组和4-48小时组额外碘对比剂暴露与AKI均无显著关联(所有p值>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to investigate whether repeated intravascular administration of iodinated contrast media (ICM) or gadolinium-based contrast agents (GBCAs) within a short interval was associated with an increased risk of post-contrast acute kidney injury (PC-AKI).
MATERIALS AND METHODS: This retrospective study included 300 patients (mean age ± standard deviation, 68.5 ± 8.1 years; 131 male and 169 female) who had undergone at least one ICM-enhanced perfusion brain CT scan, had their baseline and follow-up serum creatinine levels available, and had not undergone additional contrast-enhanced examinations 72 hours before and after a time window of interest were included. The study population was divided into three groups: single-dose group and groups of patients who had received multiple contrast administrations in the time window of interest with the minimum contrast repeat interval either within 4 hours (0-4-hour group) or between 4 to 48 hours (4-48-hour group). Multivariable logistic regression analysis was conducted to evaluate the association between AKI and repeated ICM administrations. A similar supplementary analysis was performed including both ICM and GBCA.
RESULTS: When ICM was only considered ignoring GBCA, among 300 patients, 207 patients received a single dose of ICM, 58 had repeated doses within 4 hours (0-4-hour group), and 35 patients had repeated doses between 4 to 48 hours (4-48-hour group). Most patients (> 95%) had a baseline estimated glomerular filtration rate (eGFR) of ≥ 30 mL/min/1.73 m². AKI occurred in 7.2%, 13.8%, and 8.6% of patients in the single-dose, 0-4-hour, and 4-48-hour groups, respectively. In the 0-4-hour and 4-48-hour groups, additional exposure to ICM was not associated with AKI after adjusting for comorbidities and nephrotoxic drugs (all p values > 0.05).
CONCLUSION: Repeated intravascular administrations of ICM within a short interval did not increase the risk of AKI in our study patients suspected of acute stroke with a baseline eGFR of ≥ 30 mL/min/1.73 m².
引用
- Kwon C, Kang KM, Choi YH, et al. Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval. Korean J Radiol. 2021. PMID: 34132080. doi:10.3348/kjr.2020.1153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。